Ethinylestradiol/gestodene - Bayer HealthCare Pharmaceuticals/Wyeth

Alternative Names: Arianna; Ethinylestradiol/gestodene (Mirelle); Meliane Light; Melodene; Melodia; Microgeste; Minesse; Mirelle

Latest Information Update: 09 Feb 2015

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Bayer Schering Pharma
Class Alkylated estrogenic steroids; Norpregnatrienes; Norpregnenes
Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

09 Feb 2015 Launched for Contraception/Pregnancy (Prevention) in Israel, South Africa and Thailand (PO) prior to February 2015
16 Oct 2009 Wyeth has been acquired by Pfizer
29 Dec 2006 Schering AG is now called Bayer Schering Pharma AG

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com